RAPART in Locally Advanced Non-small Cell Lung Cancer Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a Phase II/III randomized clinical trial of Radiosensitivity-Assisted Personalized Adaptive Radiotherapy Technology (RAPART) in locally advanced non-small cell lung cancer patients. The main objective is to test the overall improvement of overall survival (OS), progression free survival (PFS), and local progression free survival (LPFS) of unresectable stage III NSCLC under standard and non-standard mixed treatment conditions compared to conventional 60Gy radiotherapy.
Epistemonikos ID: eccd06be4c18115af6b96e23ef40536d26ab5446
First added on: Sep 11, 2025